Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.19NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FM.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CS.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.83NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BJ.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XDGNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDGNSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GA.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.5.2.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.2.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.53NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EU.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CM.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.2.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.43NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.28 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AY.28 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.272NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.272NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.371NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.371NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.353NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.353NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.407NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.407NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.254NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.254NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.39.1.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39.1.1 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.418NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.418NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.9.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.9.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.40NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.122NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.122NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BM.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used